OneAscent Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
OneAscent Wealth Management's GILD Position: Q1 2026 in Review
OneAscent Wealth Management reduced its Gilead Sciences (GILD) stake by 3.6% in Q1 2026, selling an estimated $11.6K and leaving 2,192 shares worth $305K. The position accounts for 0.1% of the portfolio, ranked #111.
OneAscent Wealth Management first reported a position in GILD in Q4 2020 and has held it in 16 quarters since. The position peaked at $686K in Q1 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- OneAscent Wealth Management held 2,192 shares of Gilead Sciences worth $305K as of Q1 2026.
- OneAscent Wealth Management sold 83 Gilead Sciences shares in Q1 2026, an estimated $11.6K.
- Gilead Sciences made up 0.1% of OneAscent Wealth Management's portfolio in Q1 2026, its #111 holding.
- OneAscent Wealth Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 16 quarters since.
- OneAscent Wealth Management's Gilead Sciences position peaked at $686K in Q1 2021.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on OneAscent Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.